Net Deals Web Search

Search results

1. Results From The WOW.Com Content Network

2. BioMarin Pharmaceutical - Wikipedia

   en.wikipedia.org/wiki/BioMarin_Pharmaceutical

   BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research is in enzyme replacement therapies (ERTs). BioMarin was the first company to provide therapeutics for ...

3. Ultragenyx - Wikipedia

   en.wikipedia.org/wiki/Ultragenyx

   Ultragenyx Pharmaceutical Inc. was founded in 2010 by Emil Kakkis based on his history of developing therapies for rare disease starting at Harbor-UCLA Medical Center, continuing through his role as chief medical officer of BioMarin and as founder of the EveryLife Foundation.

4. Emil Kakkis - Wikipedia

   en.wikipedia.org/wiki/Emil_Kakkis

   Emil Kakkis. Emil Kakkis (born 1960) is an American medical geneticist known for his work to develop treatments for ultra rare disorders. He is the Founder of the Everylife Foundation for Rare Disease and Founder, CEO and President of Ultragenyx Pharmaceutical Inc.

5. Will BioMarin Climb Even Higher? - AOL

   www.aol.com/news/2013-11-18-will-biomarin-climb...

   Shares of BioMarin Pharmaceuticals jumped almost 8% last Friday after the Food and Drug Administration, or FDA, released the briefing documents for the company's enzyme-replacement therapy for ...

6. Why BioMarin Shares Soared - AOL

   www.aol.com/news/2012-11-05-why-biomarin-shares...

   For premium support please call: 800-290-4726 more ways to reach us

7. BioMarin's dwarfism therapy gets FDA nod for expanded use - AOL

   www.aol.com/news/u-fda-approves-expanded...

   By Pratik Jain (Reuters) -The U.S. health regulator on Friday approved the expanded use of BioMarin Pharmaceutical's once-daily injection to treat children under the age of 5 with the most common ...